Chau-Ting Yeh

Title: The Innovations of Chau-Ting Yeh

Introduction

Chau-Ting Yeh is a notable inventor based in Taoyuan County, Taiwan. He has made significant contributions to the field of medicine, particularly in the treatment of thrombocytopenia. With a total of 4 patents to his name, Yeh's work has the potential to impact the lives of many patients suffering from various health conditions.

Latest Patents

One of Chau-Ting Yeh's latest patents focuses on the treatment of thrombocytopenia using orally administered interferon. This innovative interferon composition is designed to enhance platelet count, reduce the recurrence rate of hepatitis, and improve the social function of hepatitis patients. The method involves administering a low dose of interferon (about 5 IU to about 2500 IU of IFN-alpha) to patients in need. In particular, the biologically active interferon can be human alpha interferon or beta interferon, showcasing Yeh's commitment to advancing medical treatments.

Career Highlights

Throughout his career, Chau-Ting Yeh has worked with reputable organizations such as Amarillo Biosciences, Inc. and the National Health Research Institutes. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to the advancement of medical science.

Collaborations

Chau-Ting Yeh has collaborated with several professionals in his field, including Martin Joseph Cummins and Ching-Yuan Lee. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking solutions.

Conclusion

Chau-Ting Yeh's contributions to the field of medicine through his patents and collaborations highlight his dedication to improving patient care. His innovative approaches to treating thrombocytopenia and hepatitis demonstrate the potential for significant advancements in medical treatments.